These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28135635)

  • 1. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the identification of allosteric modulators of G-protein-coupled receptors.
    Burford NT; Watson J; Bertekap R; Alt A
    Biochem Pharmacol; 2011 Mar; 81(6):691-702. PubMed ID: 21184747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
    Christopher JA; Doré AS; Tehan BG
    Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders.
    Conn PJ; Lindsley CW; Meiler J; Niswender CM
    Nat Rev Drug Discov; 2014 Sep; 13(9):692-708. PubMed ID: 25176435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of G protein-coupled receptors.
    May LT; Avlani VA; Sexton PM; Christopoulos A
    Curr Pharm Des; 2004; 10(17):2003-13. PubMed ID: 15279541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development.
    Müller CE; Schiedel AC; Baqi Y
    Pharmacol Ther; 2012 Sep; 135(3):292-315. PubMed ID: 22728155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of G protein-coupled receptors.
    May LT; Leach K; Sexton PM; Christopoulos A
    Annu Rev Pharmacol Toxicol; 2007; 47():1-51. PubMed ID: 17009927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery.
    Wang Y; Yu Z; Xiao W; Lu S; Zhang J
    Drug Discov Today; 2021 Mar; 26(3):690-703. PubMed ID: 33301977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery.
    Bian Y; Jun JJ; Cuyler J; Xie XQ
    Eur J Med Chem; 2020 Nov; 206():112690. PubMed ID: 32818870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of conformationally thermostabilised GPCRs in drug discovery: application to fragment, structure and biophysical techniques.
    Tehan BG; Christopher JA
    Curr Opin Pharmacol; 2016 Oct; 30():8-13. PubMed ID: 27400445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in GPCR drug discovery: new agents, targets and indications.
    Hauser AS; Attwood MM; Rask-Andersen M; Schiöth HB; Gloriam DE
    Nat Rev Drug Discov; 2017 Dec; 16(12):829-842. PubMed ID: 29075003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.